Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. (Q46015851)
Jump to navigation
Jump to search
scientific article published on 11 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. |
scientific article published on 11 May 2009 |
Statements
1 reference
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. (English)
1 reference
Sarit Assouline
1 reference
Biljana Culjkovic
1 reference
Eftihia Cocolakis
1 reference
Caroline Rousseau
1 reference
Nathalie Beslu
1 reference
Abdellatif Amri
1 reference
Stephen Caplan
1 reference
Brian Leber
1 reference
Denis-Claude Roy
1 reference
Wilson H Miller
1 reference
Katherine L B Borden
1 reference
11 May 2009
1 reference
1 reference
114
1 reference
257-260
1 reference
2
1 reference
Identifiers
1 reference
1 reference